Use of frontline maintenance treatment following cytoreductive surgery in advanced high-grade serous ovarian cancer: a memorial Sloan Kettering team ovary study

被引：0
|
作者：
Finch, Lindsey [1 ]
Finlan, Michael [1 ]
Broach, Vance [1 ]
Chi, Dennis [1 ]
Roche, Kara Long [1 ]
Gardner, Ginger [1 ]
Al-Niaimi, Ahmed [1 ]
O'cearbhaill, Roisin [2 ]
Grisham, Rachel [2 ]
Abu-Rustum, Nadeem [1 ]
Sonoda, Yukio [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Surg, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV254/#957
引用
收藏
页码：A215 / A215
页数：1
相关论文
共 50 条
  • [21] SHOULD AROMATASE INHIBITORS BE USED AS MAINTENANCE TREATMENT IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS?
    Heinzelmann-Schwarz, V.
    Knipprath-Meszaros, A. M.
    Francis, J.
    Stadlmann, S.
    Vigo, F.
    Schoetzau, A.
    Singer, G.
    Vetter, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 307 - 307
  • [22] Bevacizumab (Bev) for treatment of recurrent serous borderline (SB) or low-grade serous (LGS) ovarian cancer: A retrospective review of the Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Grisham, Rachel N.
    Sala, Evis
    Zhou, Qin
    Iasonos, Alexia
    DeLair, Deborah
    Iyer, Gopa
    Hyman, David Michael
    Spriggs, David R.
    Aghajanian, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study
    Kahn, Ryan M.
    Boerner, Thomas
    Kim, Michael
    Lam, Clarissa
    Gordhandas, Sushmita
    Yeoshoua, Effi
    Zhou, Qin C.
    Iasonos, Alexia
    Al-Niaimi, Ahmed
    Gardner, Ginger J.
    Roche, Kara Long
    Sonoda, Yukio
    Zivanovic, Oliver
    Grisham, Rachel N.
    Abu-Rustum, Nadeem R.
    Chi, Dennis S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (07) : 1051 - 1059
  • [24] TESTING PREDICTION ACCURACY OF HDU ADMISSION FOLLOWING HIGH GRADE SEROUS ADVANCED OVARIAN CANCER CYTOREDUCTIVE SURGERY USING MACHINE LEARNING METHODS
    Laios, Alexandros
    Medeiros-de-Morais, Camilo De Lelis
    Tan, Yong
    Saalmink, Gwendolyn
    Otify, Mohamed
    Kaufmann, Angelika
    Broadhead, Tim
    Hutson, Richard
    Gomes de Lima, Kassio Michell
    Theophilou, George
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A111 - A111
  • [25] Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
    Azais, Henri
    Vignion-Dewalle, Anne-Sophie
    Carrier, Marine
    Augustin, Jeremy
    Da Maia, Elisabeth
    Penel, Alix
    Belghiti, Jeremie
    Nikpayam, Marianne
    Gonthier, Clementine
    Ziane, Laurine
    Mordon, Serge
    Collinet, Pierre
    Canlorbe, Geoffroy
    Uzan, Catherine
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 13
  • [26] OUTCOME OF PATIENTS WITH HIGH-GRADE SEROUS OVARIAN CANCER WHO ARE NOT SUITABLE FOR CYTOREDUCTIVE SURGERY: A RETROSPECTIVE REVIEW IN THE NORTHERN IRELAND CANCER CENTRE
    Feeney, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 673 - 673
  • [27] Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Liu, Ying L.
    Zhou, Qin C.
    Iasonos, Alexia
    Chi, Dennis S.
    Zivanovic, Oliver
    Sonoda, Yukio
    Gardner, Ginger
    Broach, Vance
    O'Cearbhaill, Roisin
    Konner, Jason A.
    Grisham, Rachel
    Aghajanian, Carol A.
    Abu-Rustum, Nadeem R.
    Tew, William
    Long Roche, Kara
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) : 1915 - 1921
  • [28] Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer
    Uehara, Takashi
    Matsuzaki, Juntaro
    Yoshida, Hiroshi
    Ogawa, Yuto
    Miura, Junichiro
    Fujimiya, Hitoshi
    Yamamoto, Yusuke
    Kawauchi, Junpei
    Takizawa, Satoko
    Yonemori, Kan
    Sakamoto, Hiromi
    Kato, Ken
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 917 - 925
  • [29] Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context
    Samoylovich, Arthur
    Jennings, Bronwyn
    Shannon, Catherine
    Coward, Jermaine I.
    Lourie, Rohan
    Riordan, John
    Lai, Nai An
    van Driel, Willemien J.
    Cabraal, Nimithri
    Jagasia, Nisha
    Chetty, Naven
    Naidu, Sanjeev
    Perrin, Lewis C.
    Barry, Sinead C.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2023, 63 (05): : 702 - 708
  • [30] Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study
    Xiaoxue Li
    Yiling Ding
    Yang Liu
    Mengyuan Yang
    Journal of Ovarian Research, 15
12345